Robuta

https://pmc.ncbi.nlm.nih.gov/articles/PMC9745424/ Genomic Testing in Localized Prostate Cancer Can Identify Subsets of African Americans With... Personalized genomic classifiers have transformed the management of prostate cancer (PCa) by identifying the most aggressive subsets of PCa. Nevertheless, the... localized prostate cancer https://www.sciencedaily.com/releases/2008/05/080515072803.htm External-beam Radiation Therapy For Localized Prostate Cancer Linked To Other Cancer | ScienceDaily Patients undergoing external-beam radiation therapy for localized prostate cancer may be at an increased risk for secondary malignancy, according to a new... external beam radiationlocalized prostate cancer https://pmc.ncbi.nlm.nih.gov/articles/PMC5906059/ Intratumoral and Intertumoral Genomic Heterogeneity of Multifocal Localized Prostate Cancer Impacts... Next-generation sequencing is revealing genomic heterogeneity in localized prostate cancer (CaP). Incomplete sampling of CaP multiclonality has limited the... localized prostate cancergenomicheterogeneity https://www.preprints.org/manuscript/202506.1608 Biomarkers in Localized Prostate Cancer: Towards a Personalized Medicine[v1] | Preprints.org Prostate-specific antigen (PSA) has been the main biomarker used for the detection and monitoring of prostate cancer for decades. However, its limited... localized prostate cancer https://www.aafp.org/pubs/afp/issues/2017/0201/p196.html Active Surveillance for Localized Prostate Cancer: No Increased Mortality, but Higher Rates of... This landmark study compared active surveillance with radical prostatectomy or radiation therapy for patients with T1c or T2 prostate cancer. The benefits of... localized prostate cancer https://pmc.ncbi.nlm.nih.gov/articles/PMC12576695/ Ultra-hypofractionated radiotherapy with focal boost for high-risk localized prostate cancer... The study aims to evaluate dosimetric properties of hypofractionated treatment plans integrating focal boost, using registered whole-mount histopathology... https://www.prweb.com/releases/research_sheds_lights_on_therapeutic_effect_of_targeted_treatment_of_localized_prostate_cancer/prweb14247465.htm Research Sheds Lights on Therapeutic Effect of Targeted Treatment of Localized Prostate Cancer Xiangtan, China (PRWEB) April 15, 2017 -- The effectiveness of the targeted therapy in the tumor treatment has now been ascertained by the research conducted... lights ontherapeutic effect https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=38303&ver=13&ContrId=228&ContrVer=2&CntrctrSelected=228*2&Cntrctr=228&name=&DocType=2&bc=AAAAgACAAAAA&= LCD - MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease (L38303) Use this page to view details for the Local Coverage Determination for MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease.